x
Filter:
Filters applied
- Psoriasis
- CVDRemove CVD filter
Author
- Admani, Shehla1
- Camhi, Maya I1
- Diaconu, Doina1
- Eichenfield, Lawrence F1
- Elder, James T1
- Fritz, Yi1
- Golden, Jackelyn B1
- Hwang, Samuel T1
- Ivanco, Tammy L1
- Joshi, Aditya A1
- Kikly, Kristine1
- Li, Yumeng1
- McCormick, Thomas S1
- Mehta, Nehal N1
- Natarajan, Balaji1
- Nijsten, Tamar1
- Playford, Martin P1
- Simon, Daniel I1
- Tom, Wynnis L1
- Wang, Yunmei1
- Ward, Nicole L1
- Zhang, Xiufen1
Keyword
- cardiovascular disease3
- 18-fluorodeoxyglucose positron emission tomography-computed -tomography1
- apoA-11
- apoB1
- apolipoprotein A-11
- apolipoprotein B-1001
- CEC1
- cholesterol efflux capacity1
- FDG-PET-CT1
- genome-wide association study1
- GWAS1
- hBD21
- HDL1
- high-density lipoprotein1
- HOMA-IR1
- homeostasis model assessment of insulin resistance1
- human β-defensin 21
- JID1
- Journal of Investigative Dermatology1
- LDL1
- lncRNA1
- NET1
- TNF1
- TNF-α1
Psoriasis
3 Results
- Original Article Immunology/InfectionOpen Archive
Protection from Psoriasis-Related Thrombosis after Inhibition of IL-23 or IL-17A
Journal of Investigative DermatologyVol. 138Issue 2p310–315Published online: September 23, 2017- Yumeng Li
- Jackelyn B. Golden
- Maya I. Camhi
- Xiufen Zhang
- Yi Fritz
- Doina Diaconu
- and others
Cited in Scopus: 25Psoriasis patients experience chronic systemic skin inflammation and develop cardiovascular comorbidities that shorten their lifespan. Whether cardiovascular disease is improved by treatment with current biologics that target disease-specific pathways is unclear. KC-Tie2 mice develop psoriasiform skin inflammation with increases in IL-23 and IL-17A and proinflammatory monocytosis and neutrophilia that precedes development of carotid artery thrombus formation. To examine whether targeted blockade of IL-23 or IL-17A in KC-Tie2 psoriasis mice improves cardiovascular outcomes, mice were treated systemically for 6 weeks with antibodies targeting IL-17A, IL-17RA, IL-12/23p40, or IL-23p19. - ReviewOpen Archive
Recent Highlights in Psoriasis Research
Journal of Investigative DermatologyVol. 137Issue 3p550–556Published online: January 4, 2017- Samuel T. Hwang
- Tamar Nijsten
- James T. Elder
Cited in Scopus: 47This article highlights recent advances in the immunology, epidemiology, and genetics/genomics of psoriasis. Advances sometimes generate more questions, and this article makes an attempt to point out where controversies might exist in the literature. Many of the articles mentioned were published in the Journal of Investigative Dermatology, but many articles from the broader scientific literature are also cited, to provide context and to add further validity for some of these key findings. Among the themes we explore are the identification of antigens in psoriasis, the co-morbidities of psoriasis, and novel integrative approaches to genome-wide association studies. - Original Article Clinical ResearchOpen Archive
Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Reveals a More Atherogenic Profile
Journal of Investigative DermatologyVol. 136Issue 1p67–73Published in issue: January, 2016- Wynnis L. Tom
- Martin P. Playford
- Shehla Admani
- Balaji Natarajan
- Aditya A. Joshi
- Lawrence F. Eichenfield
- and others
Cited in Scopus: 33Psoriasis is associated with increased cardiovascular disease in adults, but the risk profile of children with psoriasis remains to be fully characterized. We measured lipoprotein composition and function in 44 patients with pediatric psoriasis and 44 age- and sex-matched healthy controls, using nuclear magnetic resonance spectroscopy and a validated ex vivo assay of high-density lipoprotein cholesterol efflux capacity. The mean age of the patients was 13 years and the population was ethnically diverse.